Compare · GWH vs TMO
GWH vs TMO
Side-by-side comparison of ESS Tech Inc. (GWH) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- GWH operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $176.13B, about 6514.2x GWH ($27.0M).
- Over the past year, GWH is down 29.0% and TMO is up 17.4% - TMO leads by 46.4 points.
- TMO has been more active in the news (19 items in the past 4 weeks vs 12 for GWH).
- TMO has more recent analyst coverage (25 ratings vs 16 for GWH).
- Company
- ESS Tech Inc.
- Thermo Fisher Scientific Inc
- Price
- $0.92-7.74%
- $473.94-1.69%
- Market cap
- $27.0M
- $176.13B
- 1M return
- -16.72%
- +2.47%
- 1Y return
- -28.98%
- +17.39%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 12
- 19
- Recent ratings
- 16
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest GWH
- Director Wellman Alexi was granted 13,513 shares, increasing direct ownership by 35% to 52,399 units (SEC Form 4)
- Director Quarls Harry was granted 13,513 shares, increasing direct ownership by 24% to 68,769 units (SEC Form 4)
- Director Nijhawan Sandeep was granted 13,513 shares, increasing direct ownership by 47% to 42,563 units (SEC Form 4)
- Director Hossfeld Rich was granted 13,513 shares, increasing direct ownership by 49% to 41,372 units (SEC Form 4)
- Director Garabedian Raffi was granted 13,513 shares, increasing direct ownership by 34% to 53,185 units (SEC Form 4)
- ESS Tech Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Chief Financial Officer Suhadolnik Kate Eileen sold $3,389 worth of shares (3,657 units at $0.93), decreasing direct ownership by 2% to 160,757 units (SEC Form 4) (tax liability)
- Officer Goodman Kelly F. sold $4,850 worth of shares (5,233 units at $0.93), decreasing direct ownership by 2% to 210,620 units (SEC Form 4) (withholding tax)
- ESS to Present in Clean Energy Group's Beyond Lithium Webinar Series on June 3, 2026
- Sidoti Events, LLC's May Micro-Cap Virtual Conference
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)